-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
- Xeris Biopharma Holdings, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.14 USD/shares, a 16.7% decline year-over-year.
- Xeris Biopharma Holdings, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -0.47 USD/shares, a 17.5% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual Earnings Per Share, Basic for 2023 was -0.45 USD/shares, a 35.7% increase from 2022.
- Xeris Biopharma Holdings, Inc. annual Earnings Per Share, Basic for 2022 was -0.7 USD/shares, a 54.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)